Breast cancer screening software RlapsRisk ™ BC

medicaloncologydiagnostic

Assess the risk of breast cancer relapse RlapsRisk ™ BC is an AI diagnostic to help pathologists and oncologists determine the right treatment pathway for early breast cancer patients Revolutionize breast cancer care management by democratizing access to actionable medical insights 14 secs Incidence is high. Every 14 seconds, across the globe, a woman is diagnosed with breast cancer. 2 +20% Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. 2 10% Approximately 10% of all patients will relapse after their initial treatment each year. 3 RlapsRisk BC Our research shows accurate discrimination between high and low risk of relapse 1 Testing Suitable for adults with primary invasive breast cancer (ER+/HER2-) Cumulative sensitivity Cumulative sensitivity is greater than those obtained by standard clinical scores 1 Dynamic specificity Achieves 80% specificity for post-treatment, time-dependent accuracy at 5 years 1 Digital pathology Intended to work with surgically resected tissue on digitized slides